1. Home
  2. IZM vs NXTS Comparison

IZM vs NXTS Comparison

Compare IZM & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICZOOM Group Inc.

IZM

ICZOOM Group Inc.

HOLD

Current Price

$0.26

Market Cap

4.5M

ML Signal

HOLD

Logo Nexentis Technologies Inc. Common Stock

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$1.87

Market Cap

5.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IZM
NXTS
Founded
2011
2009
Country
China
Israel
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
5.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IZM
NXTS
Price
$0.26
$1.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
211.9K
61.9K
Earning Date
10-24-2025
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$263,445.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.55
52 Week High
$2.73
$23.80

Technical Indicators

Market Signals
Indicator
IZM
NXTS
Relative Strength Index (RSI) 43.39 39.05
Support Level $0.24 $1.43
Resistance Level $0.30 $2.16
Average True Range (ATR) 0.03 0.21
MACD 0.00 0.12
Stochastic Oscillator 38.27 56.16

Price Performance

Historical Comparison
IZM
NXTS

About IZM ICZOOM Group Inc.

ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: